fasudil has been researched along with Diathesis in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Excerpt | Relevance | Reference |
---|---|---|
"Fasudil treatment improved cognitive function and central nervous system (CNS) injury, and decreased SC susceptibility in rats." | 1.46 | Effect of fasudil on cognitive function following status convulsion in rats. ( Cheng, L; Han, W; He, R; Jiang, L; Song, X; Tang, X, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, R | 1 |
Han, W | 1 |
Song, X | 1 |
Tang, X | 1 |
Cheng, L | 1 |
Jiang, L | 1 |
1 other study available for fasudil and Diathesis
Article | Year |
---|---|
Effect of fasudil on cognitive function following status convulsion in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; CA1 Region, Hippocampal; Cognition; Disease | 2017 |